Ország: Kanada
Nyelv: angol
Forrás: Health Canada
SODIUM CHLORIDE; POTASSIUM CHLORIDE
BAXTER CORPORATION
B05BB01
ELECTROLYTES
900MG; 300MG
LIQUID
SODIUM CHLORIDE 900MG; POTASSIUM CHLORIDE 300MG
INTRAVENOUS
1000ML
Ethical
REPLACEMENT PREPARATIONS
Active ingredient group (AIG) number: 0213340002; AHFS:
APPROVED
2012-12-10
Potassium Chloride in 0.9% Sodium Chloride Injection, USP Prescribing Information _ _ _Page 1 of 15_ PRESCRIBING INFORMATION POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION, USP IN PLASTIC CONTAINER VIAFLEX Container 20mmol/L Potassium Chloride in Sodium in 0.9% Chloride Injection 40mmol/L Potassium Chloride in Sodium in 0.9% Chloride Injection SOLUTION FOR INFUSION Solutions Affecting the Electrolyte Balance BAXTER CORPORATION Mississauga, ON L5N 0C2 Date of Revision: December 10, 2018 Control No. 221539 Potassium Chloride in 0.9% Sodium Chloride Injection, USP Prescribing Information _ _ _Page 2 of 15_ TABLE OF CONTENTS SUMMARY PRODUCT INFORMATION ........................................................................3 INDICATIONS AND CLINICAL USE ..............................................................................3 CONTRAINDICATIONS ...................................................................................................3 WARNINGS AND PRECAUTIONS ..................................................................................3 ADVERSE REACTIONS ....................................................................................................8 DRUG INTERACTIONS ....................................................................................................9 DOSAGE AND ADMINISTRATION ..............................................................................10 INSTRUCTIONS FOR USE AND HANDLING AND DISPOSAL ................................11 DIRECTIONS FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER ......................11 OVERDOSE ......................................................................................................................12 ACTION AND CLINICAL PHARMACOLOGY ............................................................13 STORAGE AND STABILITY ..........................................................................................13 DOSAGE FORMS, COMPOSITION AND PACKAGING .............................................13 Potassium Chloride in 0.9% Sodium Chlo Olvassa el a teljes dokumentumot